MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIGELOW, L. B.
Right arrow Articles by UDENFRIEND, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIGELOW, L. B.
Right arrow Articles by UDENFRIEND, S.

Molecular Pharmacology, Vol 5, 565-571, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Increased Synthesis of Catecholamines and Their Metabolites following the Administration of Phenoxybenzamine

LLEWELLYN B. BIGELOW 1, WALLACE DAIRMAN 1, HANS WEIL-MALHERBE 1, and SIDNEY UDENFRIEND 1

1 Laboratory of Clinical Psychopharmacology, Section on Neurochemistry, Division of Special Mental Health Research, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C. 20032

The over-all synthesis rate of catecholamines was determined in control and phenoxybenzamine-treated rats both by measuring the incorporation of 14C-L-tyrosine into norepinephrine and by assaying all the known major urinary metabolites of epinephrine and norepinephrine. The phenoxybenzamine-stimulated increase in synthesis of these hormones is firmly established. Consideration of the results of analysis of urinary metabolites reveals that (a) there is a large turnover of epinephrine and norepinephrine that must take place in sites not usually studied, and (b) studies of metabolism based on the intravenous administration of labeled norepinephrine must be interpreted with reserve.

Submitted on June 3, 1969




This article has been cited by other articles:


Home page
ScienceHome page
R. Weinshilboum and J. Axelrod
Serum Dopamine-beta-Hydroxylase: Decrease after Chemical Sympathectomy
Science, September 3, 1971; 173(4000): 931 - 934.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics